Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Asia 210

Product Description

asia_210_system_480 copy.gif

Asia is a revolutionary range of advanced flow chemistry products from Syrris. It has been designed by chemists for chemists to enable the widest variety of chemical reactions and ultimate ease of use. The proprietary technology allows automated experiments with or without a PC.

Asia offers maximum chemical resistance with an extensive range of temperatures, pressures, and reaction times on scales from mg to kg.
Asia 210 is Syrris' entry level system for totally automated synthesis of a solution phase reaction. Centrally controlled by the intelligent Asia Pump and Asia Automator, the Asia 210 system also includes a Pressurized Input Store, Glass Microreactor Chip, Chip Climate Controller, Pressure Controller and Product Collector.


• Wider range of chemistries
• Flexible to meet chemist needs (and budget)
• Integration of synthesis, work-up and analysis
• Safer and cleaner reactions
• More reactions in less time
• Maximum chemical resistance
• Ideal for synthesis, rapid optimization and scale-up
• Robust and easy to use
Product Asia 210
Company Syrris Ltd - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Syrris Ltd - Product Directory
Unit 1, Anglian Business Park Orchard Road, Royston Herts SG8 5TW United Kingdom

Tel: +44 (0) 1763 242555
Fax: +44 (0) 1763 242 992

Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos